search
Back to results

Effect of External Counter Pulsation on Ischemic Stroke

Primary Purpose

Ischemic Stroke

Status
Unknown status
Phase
Phase 3
Locations
China
Study Type
Interventional
Intervention
External counter pulsation (ECP)
Sponsored by
Eighth Affiliated Hospital, Sun Yat-sen University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ischemic Stroke focused on measuring ischemic stroke, external counter pulsation, mRS

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinical diagnosis of ischemic stroke
  • Exclusion cerebral hemorrhage after CT scan
  • NIH Stroke Scale (NIHSS)≥4
  • Modified Rankin Scale (mRS) 0-1
  • Signed informed consent

Exclusion Criteria:

  • Obvious aortic insufficiency;
  • Aortic aneurysm or aortic dissection;
  • Coronary fistula or severe coronary aneurysm;
  • Not controlled bleeding disease with INR>2.0 ;
  • Symptomatic Congestive heart failure
  • Valvular heart disease, congenital heart diseases, cardiomyopathies
  • Cerebral hemorrhage within six months;
  • Uncontrolled hypertension, defined as SBP≥180mmHg or DBP≥110mmHg;
  • Lower limb infection;
  • Deep venous thrombosis;
  • Progressive malignancies or diseases with poor prognosis

Sites / Locations

  • Shenzhen Research Institute, The Chinese University Hong Kong
  • The Second Affiliated Hospital of Zhengzhou University
  • The Second Affiliated Hospital of Xi'an Jiaotong University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

External Counter Pulsation (ECP) group

Control group

Arm Description

A standard ECP protocol involves 35 one-hour sessions (once per day, 5 days a week) and continuous for 7 weeks. ECP consists of three sets of pneumatic cuffs attached to each of the patient's legs at the calf and lower and upper thigh. The inflation of the cuffs is triggered by a computer, and timing of the inflation is based on the R wave of the electrocardiogram. The ECP therapist adjusts the inflation and deflation timing to provide optimal blood movement per a finger plethysmogram waveform reading.

Guideline-driven standard medical treatment

Outcomes

Primary Outcome Measures

modified Rankin Scale (mRS) score
3-month mRS score after stroke

Secondary Outcome Measures

NIH Stroke Scale (NIHSS) score
3-month NIHSS score after stroke
Barthel Index (BI)
3-month BI after stroke
mini-mental state examination (MMSE) Score
3-month MMSE after stroke
Ischemic area of Cerebral CT image
Ischemic area of 3-month Cerebral CT image
Transcranial doppler (TCD) flow velocities
transcranial doppler (TCD) flow velocities

Full Information

First Posted
February 28, 2017
Last Updated
December 12, 2017
Sponsor
Eighth Affiliated Hospital, Sun Yat-sen University
Collaborators
Shenzhen Research Institute, The Chinese University Hong Kong, Second Affiliated Hospital of Xi'an Jiaotong University, Second Affiliated Hospital of Zhengzhou University
search

1. Study Identification

Unique Protocol Identification Number
NCT03075137
Brief Title
Effect of External Counter Pulsation on Ischemic Stroke
Official Title
Effect of External Counter Pulsation on IschemicStroke (ECP-STROKE)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2017
Overall Recruitment Status
Unknown status
Study Start Date
June 10, 2018 (Anticipated)
Primary Completion Date
May 31, 2019 (Anticipated)
Study Completion Date
June 30, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Eighth Affiliated Hospital, Sun Yat-sen University
Collaborators
Shenzhen Research Institute, The Chinese University Hong Kong, Second Affiliated Hospital of Xi'an Jiaotong University, Second Affiliated Hospital of Zhengzhou University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Stroke is a prevalent atherosclerosis vascular disease with high mortality, external counter pulsation (ECP) is an approved noninvasive therapy for angina, congestive heart failure, myocardial infarction, and cardiogenic shock that augments blood flow to cardiac and systemic circuits, which improves the flow volume in the carotid. Though ECP is Ⅱa recommendation for stroke management, no multi-center control clinical study has been reported for prognosis of stroke. The aim of this study is to evaluate the effect of ECP on stoke. To address this assumption, investigators enroll subjects with ischemic stroke and randomized into control or ECP group, the ECP intervention will be carried out with a standard protocol which involves 35 one-hour sessions (5 days a week) for continuous 7 weeks. The primary endpoint is mRS score in 3 months, secondary endpoints include NIHSS, BI and MMSE score, recurrence of stroke in 3 months, glycolipid metabolism, transcranial doppler (TCD) flow velocities and endothelial function.
Detailed Description
Cardiovascular disease is the leading cause of mortality worldwide, accounting for 17.5 million deaths per year; 6.7 million of these deaths are related to stroke. Over 80% of strokes are classified as ischemic. External counter pulsation (ECP) is a non-invasive method which consists of three sets of pneumatic cuffs attached to each of the patient's legs at the calf and lower and upper thigh. The inflation of the cuffs is triggered by a computer, and timing of the inflation is based on the R wave of the electrocardiogram. The ECP therapist adjusts the inflation and deflation timing to provide optimal blood movement per a finger plethysmogram waveform reading. This produces a retrograde flow of blood in the aorta resulting in a diastolic augmentation of blood flow and also an increase in venous return, which leads to an improved carotid perfusion pressure. Cumulative evidences demonstrate that ECP can augment peak diastolic and mean middle cerebral artery flow velocities, accelerate rehabilitation after stroke, however, no multi-center study on the effect of ECP on the prognosis of stroke has been reported. Thus, this study is designed to enroll 380 subjects with ischemic stroke after evaluation of glycolipid metabolism, heart function, transcranial doppler (TCD) flow velocities, endothelial function, NIHSS, BI and MMSE score, they will be randomized into ECP intervention or control group. All subjects receive Guideline-driven standard medical treatment, ECP will be carried out with a standard protocol which involves 35 one-hour sessions (5 days a week) for continuous 7 weeks. Up to the end of ECP intervention, mRS of subjects will be follow up to 3 months, meanwhile, items as above will be retested for comparison.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemic Stroke
Keywords
ischemic stroke, external counter pulsation, mRS

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
380 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
External Counter Pulsation (ECP) group
Arm Type
Experimental
Arm Description
A standard ECP protocol involves 35 one-hour sessions (once per day, 5 days a week) and continuous for 7 weeks. ECP consists of three sets of pneumatic cuffs attached to each of the patient's legs at the calf and lower and upper thigh. The inflation of the cuffs is triggered by a computer, and timing of the inflation is based on the R wave of the electrocardiogram. The ECP therapist adjusts the inflation and deflation timing to provide optimal blood movement per a finger plethysmogram waveform reading.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Guideline-driven standard medical treatment
Intervention Type
Device
Intervention Name(s)
External counter pulsation (ECP)
Intervention Description
standard ECP protocol involves 35 one-hour sessions (once per day, 5 days a week) and continuous for 7 weeks. ECP consists of three sets of pneumatic cuffs attached to each of the patient's legs at the calf and lower and upper thigh. The inflation of the cuffs is triggered by a computer, and timing of the inflation is based on the R wave of the electrocardiogram. The ECP therapist adjusts the inflation and deflation timing to provide optimal blood movement per a finger plethysmogram waveform reading.
Primary Outcome Measure Information:
Title
modified Rankin Scale (mRS) score
Description
3-month mRS score after stroke
Time Frame
Change from Baseline at 3 months
Secondary Outcome Measure Information:
Title
NIH Stroke Scale (NIHSS) score
Description
3-month NIHSS score after stroke
Time Frame
Change from Baseline at 3 months
Title
Barthel Index (BI)
Description
3-month BI after stroke
Time Frame
Change from Baseline at 3 months
Title
mini-mental state examination (MMSE) Score
Description
3-month MMSE after stroke
Time Frame
Change from Baseline at 3 months
Title
Ischemic area of Cerebral CT image
Description
Ischemic area of 3-month Cerebral CT image
Time Frame
Change from Baseline at 3 months
Title
Transcranial doppler (TCD) flow velocities
Description
transcranial doppler (TCD) flow velocities
Time Frame
Change from Baseline at 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of ischemic stroke Exclusion cerebral hemorrhage after CT scan NIH Stroke Scale (NIHSS)≥4 Modified Rankin Scale (mRS) 0-1 Signed informed consent Exclusion Criteria: Obvious aortic insufficiency; Aortic aneurysm or aortic dissection; Coronary fistula or severe coronary aneurysm; Not controlled bleeding disease with INR>2.0 ; Symptomatic Congestive heart failure Valvular heart disease, congenital heart diseases, cardiomyopathies Cerebral hemorrhage within six months; Uncontrolled hypertension, defined as SBP≥180mmHg or DBP≥110mmHg; Lower limb infection; Deep venous thrombosis; Progressive malignancies or diseases with poor prognosis
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Guifu Wu, PhD
Phone
+8615989892111
Email
wuguifu@mail.sysu.edu.cn
First Name & Middle Initial & Last Name or Official Title & Degree
Jianhang Du, PhD
Phone
+8613652851566
Email
zsudjhang@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guifu Wu, PhD
Organizational Affiliation
Eighth Affiliated Hospital, Sun Yat-sen University
Official's Role
Study Chair
Facility Information:
Facility Name
Shenzhen Research Institute, The Chinese University Hong Kong
City
Shenzhen
State/Province
Guangdong
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Li Xiong, PhD
Phone
+8613688847419
Facility Name
The Second Affiliated Hospital of Zhengzhou University
City
Zhengzhou
State/Province
Henan
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bing Xia, PhD
Phone
+86 13663839489
Facility Name
The Second Affiliated Hospital of Xi'an Jiaotong University
City
Xi'an
State/Province
Shanxi
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Haifeng Yuan, PhD
Phone
+86 13572234796

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Effect of External Counter Pulsation on Ischemic Stroke

We'll reach out to this number within 24 hrs